IP Library Granted Patent US 9,012,617
Granted Patent B2
US 9,012,617 · App. 13/443,953 · Granted Apr 21, 2015

Detection reagents for tyrosine kinase activity and methods of use thereof

Inventors: Matthew Dalva (Narberth, PA); Julia X. Zhu (Bern, CH)
Assignee: The Trustees of The University of Pennsylvania
C12Q1/485G01N33/5044G01N33/582
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,012,617
App. No.
13/443,953
Granted
Apr 21, 2015
Kind
B2
Abstract

Dual colored fluorescent indicators of specific tyrosine kinase activity and methods of use thereof are disclosed.

Claims (13)

1. A genetic construct encoding a dual colored, specific, tyrosine kinase enzyme indicator molecule for assessing tyrosine kinase activity in a cell, said construct comprising the following sequences in operable linkage in the recited order:

a) a promoter sequence effective to drive expression of said construct in a target cell;

b) a sequence encoding a first fluorescent reporter molecule that is insensitive to changes in phosphorylation;

c) sequences encoding at least two distinct consensus phosphorylation sites for tyrosine phosphorylation wherein the consensus phosphorylation sites are selected from the group consisting of SEQ ID NOS: 43-86;

d) a sequence encoding a circularly permuted second fluorescent reporter molecule, where

said first and second fluorescent reporter molecules fluoresce different colors; and

e) an SH2 interacting domain from a tyrosine kinase selected from the group consisting of

fyn, src, lck, Csk, p85, Ab1, RasGAP, Crk, Nck, She, FRS2, Grb2, SH2B, rAPS, PLC-g, Gab1, Grb7, Grb14, and yes, wherein phosphorylation of tyrosine in one or more of said consensus phosphorylation sites in c) causes said SH2 interacting domain to bind to said consensus phosphorylation site thereby causing the fluorescence signal of the second fluorescent reporter molecule to increase.

2. The genetic construct of claim 1 where the SH2 interacting domain is selected from the group consisting of fyn, src, RasGAP, Crk, and Nck.

3. The genetic construct of claim 2 where the SH2 interacting domain is fyn.

4. The genetic construct of claim 2 where the consensus phosphorylation sites are selected from the group consisting of SEQ ID NOS: 51-53.

5. An expression vector containing the genetic construct of claim 1 .

6. An isolated host cell containing the expression vector of claim 5 .

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 16, 2015
From: ZHU, JULIA X.; DALVA, MATTHEW
To: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
Reel/Frame 035173/0603 →
CONFIRMATORY LICENSE Recorded Jul 2, 2013
From: UNIVERSITY OF PENNSYLVANIA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 030745/0251 →
Continuity (2)
Provisional Application 61473847 · Apr 11, 2011
Related Publication 20120270240A1 · Oct 25, 2012